KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells

Although the KAI1/CD82 protein has been reported to inhibit cell metastasis in many studies. its mechanism of action has not yet been fully elucidated. In the present study, we investigated the possible effects of KAI1/CD82 on the metastatic phenotype in H1299 lung carcinoma cells. These studies were based Oil the pivotal role that the acquisition of motile phenotype plays on the initial steps of metastasis. KAII/CD82mediated morphological changes were observed using phase contrast microscopy. We report here, that a KAI1/CD82-induced phenotypic change was involved in the decrease of Rac 1 expression and GTPase activity. However, we found that KAI1/CD82 did not regulate Rac 1 mRNA levels. This suggests the existence of another regulatory mechanism of Rac 1 protein maturation or activation. To identify the signaling pathway of Rac 1 regulation, we investigated the PI3K/Akt/mTOR pathway, since the PI3K/Akt pathway regulates Rac 1 activation and mTOR is known to play a regulatory role in protein translation. H 1299/CD82-transfectants showed lower mTOR expression and cell growth than the control group. The data obtained from this study suggested that KAI1/CD82 decreased the metastatic phenotype of H1299 lung carcinoma cells by down-regulating Rac 1 expression through the PI3K/Akt/mTOR pathway. Copyright (C) 2008 John Wiley & Sons, Ltd.